But GAO insists cancer care won't suffer next yearOncologists should be able to afford the new, reduced payments for medications that take effect in January, claims the Government Accountability Office in a new report ("Medicare Chemotherapy Drugs: New Drug And Administration Fees Are Closer To Providers' Costs," GAO-05-142R). The GAO studied 16 drugs commonly billed by oncologists and found that Medicare payments would be 22 percent above oncologists' costs in 2004 and 6 percent above their costs in 2005. The American Society for Clinical Oncology responded that a survey of its members found that payments would be only...
To read the full article, sign in and subscribe to tci Part B Insider.
Keep pace with evolving Medicare regulations with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI’s Part B Insider will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4800 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.